Streetbeat News

Products Services

SNY

Sanofi has entered into a licensing agreement with Radiomedix and Orano Med for the commercialization of AlphaMedix, a treatment for neuroendocrine tumors. Sanofi will handle global commercialization, while Orano Med will manage manufacturing. Radiomedix and Orano Med will receive an upfront payment of €100M and up to €220M in sales milestones.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:16 am

TMUS

T-Mobile US, Inc. successfully sent the first wireless emergency alert via SpaceX's Starlink satellites, marking a significant advancement in emergency communication. This partnership aims to provide connectivity in remote areas, with plans for further testing and commercial launch.

Portfolio Pulse from Anan Ashraf

September 12, 2024 | 8:14 am

FITE

ITA

MISL

NVDA

PPA

XAR

Morgan Stanley advises investors to shift towards defensive stocks as the AI market loses momentum, following a decline in semiconductor shares, including Nvidia. The firm suggests focusing on sectors like utilities, staples, and healthcare amid a slowing labor market.

Portfolio Pulse from Benzinga Neuro

September 12, 2024 | 7:59 am

BTG

B2Gold and the Mali government have finalized an agreement on the Fekola Complex, expediting key mining permits. This includes the exploitation permits for Fekola Regional and the approval of the exploitation phase of Fekola underground. The agreement ensures stability under Mali's mining codes and resolves existing disputes.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:58 am

IVBIY

Innovent's Phase 3 DREAMS-2 trial shows mazdutide's superiority over dulaglutide in glycemic control and weight reduction for Chinese Type 2 Diabetes patients. Mazdutide also improved cardiometabolic risk factors.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:55 am

AAPL

AMZN

MSFT

Apple has started producing its iPhone 16 series in India, marking a shift from its traditional reliance on China. This move is part of a broader trend among tech giants like Apple, Microsoft, and Amazon, who are diversifying production away from China due to geopolitical tensions and economic risks.

Portfolio Pulse from Benzinga Neuro

September 12, 2024 | 7:46 am

GOOG

GOOGL

MSFT

NVDA

Nvidia's stock surged over 8% following CEO Jensen Huang's comments on AI's potential beyond data centers, sparking a broader tech sector rally. Experts highlighted Nvidia's oversold status and the ongoing demand for AI, with significant investments from major tech companies. Nvidia's stock is up 136% year-to-date.

Portfolio Pulse from Shanthi Rexaline

September 12, 2024 | 7:34 am

META

Meta Platforms CEO Mark Zuckerberg attracted thousands to a sold-out live podcast event at the Chase Center in San Francisco, discussing future trends in social media, technology, and AI.

Portfolio Pulse from Ananya Gairola

September 12, 2024 | 7:29 am

BHE

Benchmark Electronics has opened its fourth facility in Penang, enhancing its semiconductor and aerospace services. This expansion allows for greater vertical integration and adds critical capacity and capabilities to its operations.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:21 am

JNJ

The FDA has approved Johnson & Johnson's TREMFYA for adults with moderately to severely active ulcerative colitis. This makes TREMFYA the first dual-acting interleukin-23 inhibitor approved for this condition, showing significant results in clinical trials.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:17 am